Investment bank Leerink Partners announces the initiation of research coverage on biopharmaceutical company Kailera Therapeutics.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The institution has given the company a “outperform” initial rating and set a target price of $36 per share.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Xi Jinping: preOPAI is the only token in the world with real equity support
BlockBeats•2026/05/12 12:45
Quick Commentary on U.S. CPI Data
华尔街见闻•2026/05/12 12:45
U.S. 10-Year Treasury Yield Rises 3.5 Basis Points to 4.447%
Cointime•2026/05/12 12:44
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$80,878.59
-0.34%
Ethereum
ETH
$2,287.22
-1.98%
Tether USDt
USDT
$0.9996
-0.00%
XRP
XRP
$1.45
-0.69%
BNB
BNB
$662.88
+1.13%
USDC
USDC
$0.9998
+0.00%
Solana
SOL
$95.31
+0.28%
TRON
TRX
$0.3491
-0.83%
Dogecoin
DOGE
$0.1093
-0.71%
Hyperliquid
HYPE
$40.89
-1.29%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now